Improvement in disability after alemtuzumab treatment of multiple sclerosis is associated with neuroprotective autoimmunity

Overview of attention for article published in Brain, July 2010

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

So far, Dimensions has found 149 publications that cite this research output.

Article in Journal of Neuroimmunology (August 2023)

Book chapter (July 2023)

Article in Clinica Chimica Acta (July 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.